Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Cumbo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
JAMA|July 25, 1977
Tissue persistence of gentamicin in manJ J Schentag, W J Jusko, M E Plaut, et al.
Therapeutic Drug Monitoring|December 1, 1993
The development of a bedside algorithm capable of targeting anti-endotoxins to the responder subpopulationsM C Birmingham, D E Nix, T J Cumbo, et al.
The Annals of Pharmacotherapy|July 1, 1994
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoximeT F Goss, A Forrest, D E Nix, et al.
The American Journal of Medicine|November 1, 1991
Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibioticsJ A Paladino, H E Sperry, J M Backes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection controlJ J Schentag, J M Hyatt, J R Carr, et al.
The American Journal of Medicine|April 27, 1987
Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infectionsD E Nix, M F Sands, C A Peloquin, et al.
Infection Control and Hospital Epidemiology|April 1, 1997
Changing the infection control paradigm from off-line to real time: the experience at Millard Fillmore Health SystemJ R Carr, P Fitzpatrick, J L Izzo, et al.
Seminars in Respiratory Infections|January 22, 1998
In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistanceJ J Schentag, M C Birmingham, J A Paladino, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryJ J Schentag, C H Ballow, A L Fritz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
JAMA|July 25, 1977
Tissue persistence of gentamicin in manJ J Schentag, W J Jusko, M E Plaut, et al.
Therapeutic Drug Monitoring|December 1, 1993
The development of a bedside algorithm capable of targeting anti-endotoxins to the responder subpopulationsM C Birmingham, D E Nix, T J Cumbo, et al.
The Annals of Pharmacotherapy|July 1, 1994
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoximeT F Goss, A Forrest, D E Nix, et al.
The American Journal of Medicine|November 1, 1991
Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibioticsJ A Paladino, H E Sperry, J M Backes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection controlJ J Schentag, J M Hyatt, J R Carr, et al.
The American Journal of Medicine|April 27, 1987
Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infectionsD E Nix, M F Sands, C A Peloquin, et al.
Infection Control and Hospital Epidemiology|April 1, 1997
Changing the infection control paradigm from off-line to real time: the experience at Millard Fillmore Health SystemJ R Carr, P Fitzpatrick, J L Izzo, et al.
Seminars in Respiratory Infections|January 22, 1998
In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistanceJ J Schentag, M C Birmingham, J A Paladino, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryJ J Schentag, C H Ballow, A L Fritz, et al.
Pageof 2